EBV Reactivation and MIS-C After COVID-19 in an Adolescent

Background: Multisystem inflammatory syndrome in children (MIS-C) is a post-infectious complication of SARS-CoV-2 characterized by systemic hyperinflammation and multiorgan involvement. Emerging evidence suggests that the immune dysregulation associated with MIS-C may facilitate reactivation of latent viruses, including Epstein–Barr virus (EBV). We describe an adolescent with MIS-C and concomitant EBV DNAemia, raising the possibility of EBV reactivation during the hyperinflammatory response.

Case Presentation: A 15-year-old girl presented with a 3-day history of persistent high-grade fever (maximum temperature, 39°C) accompanied by rigors, facial and periorbital edema, generalized abdominal pain, and decreased urine output. On admission, she was moderately unwell but hemodynamically stable (blood pressure, 102/78 mmHg; heart rate, 120 beats/min). Clinical examination revealed pharyngeal erythema, generalized abdominal tenderness, hepatosplenomegaly, pallor, and facial edema.

Initial laboratory investigations demonstrated leukopenia, neutropenia, and thrombocytopenia (white blood cell count, 2,800/μL; absolute neutrophil count, 1,140/μL; platelet count, 74,000/μL; hemoglobin, 12.4 g/dL). Respiratory multiplex PCR was positive for rhinovirus/enterovirus, while EBV DNA was detected in peripheral blood and EBV IgG was positive. Electrocardiography revealed repolarization abnormalities, although echocardiography was normal. Empirical cefuroxime and intravenous fluids were initiated.

On the second day of hospitalization, her clinical condition deteriorated, with persistent high-grade fever and worsening cytopenias (white blood cell count, 2,500/μL; platelet count, 65,000/μL; hemoglobin, 11.6 g/dL). SARS-CoV-2 nucleocapsid-specific IgM antibodies were positive. Peripheral blood immunophenotyping and serum immunoglobulin levels were normal for age. Macrophage activation syndrome was initially considered, and intravenous immunoglobulin (1 g/kg/day for 2 consecutive days) was administered.

The combination of persistent fever, gastrointestinal manifestations, hematological abnormalities, evidence of previous SARS-CoV-2 infection, and electrocardiographic changes supported the diagnosis of MIS-C. Methylprednisolone and aspirin were subsequently added to the therapeutic regimen.

Learning Points: The final diagnosis was MIS-C associated with SARS-CoV-2 infection, accompanied by EBV DNAemia in the presence of positive EBV IgG, suggesting possible reactivation of a previous EBV infection. Emerging evidence indicates that MIS-C-associated immune dysregulation may facilitate EBV reactivation through impaired antiviral T-cell responses, potentially contributing to the hyperinflammatory milieu. However, EBV reactivation cannot be definitively established from EBV PCR positivity and IgG seropositivity alone, and a causal role for EBV in MIS-C cannot be inferred. This case highlights the potential interaction between latent viral infections and the dysregulated immune response of MIS-C and emphasizes the importance of considering concomitant viral reactivation in children with atypical or severe hyperinflammatory presentations.